mmol/L before the initiation of ischemia, which we termed "K'-modified ischemia." Ischemia initiated at a normal [K+] e ("unmodified ischemia") resulted in a mean activation delay in the center of the ischemic zone of 55+±26 milliseconds after 5 minutes of ischemia and a decrease in epicardial longitudinal conduction velocity from 53 to 21 cm/s before the onset of conduction block. K'-modified ischemia resulted in a mean activation delay in the center of the ischemic zone of 181±8 milliseconds and a decrease in epicardial longitudinal conduction to less than 10 cm/s. K'-modified ischemia was associated with ventricular fibrillation in 85% of episodes compared with 28% of episodes of unmodified ischemia (P<.01). Verapamil prevented the occurrence of marked activation delay during K'-modified ischemia, producing local activation block following a maximum activation delay of 74+25 milliseconds. In two experiments, responses mediated by the slow inward current were produced by regional K' elevation to 15 to 16 mmol/L, followed by concomitant regional administration of epinephrine (10-`mol/L). Regional [K+]e elevation alone to this level resulted in local activation block following a maximum activity delay of 70 to 80 milliseconds, whereas administration of epinephrine in combination with high [K'], resulted in return of local activation with an activation delay of 160 to 180 milliseconds (ie, similar to that during K'-modified ischemia).
Conclusions Compared with unmodified ischemia, K+-modified ischemia resulted in marked activation delay and a high incidence of ventricular fibrillation. 1.5 mL -g of heart tissue`min`.9-1 A Doppler flow probe placed in the shunt was used to monitor the flow in the shunt.
A sidearm in the shunt catheter was used for direct infusion of KCl solution into the distal LAD bed. Flow through this sidearm was controlled by a second roller pump that was calibrated between 0 and 2 mL/min. A diagram of the experimental preparation is given in Fig 1. A glass cover was placed over the sternotomy to maintain the temperature and humidity on the surface of the heart. A temperature probe (Yellow Springs Instrument Co) was placed intramurally within the bed perfused by the LAD shunt to monitor intramural temperature. Atrial pacing was used as necessary to maintain heart rate between 100 and 120 beats per minute during all experimental events. (3 and 10 mmol/L KCI for K' electrodes, pH 6.0, and 8.0 for H' electrodes). Only electrodes that demonstrated a stable baseline (drift less than 1 mV/h) and 95% to 105% of the predicted Nernstian slope (56-to 62-mV shift per decade change in K' or H' activity at room temperature) were used. After electrode insertion, the in vivo performance of the K' electrodes was tested by methods that we have used previously.12-14 At the end of each experiment, the electrodes were removed from the heart and retested in vitro to confirm stable function throughout the experiment.
Multiple pairs of Teflon-coated stainless steel wires were used to record bipolar electrograms from which activation times were determined. One K' or H+-sensitive electrode, along with its reference and two stainless-steel wires for recording bipolar electrograms, constituted one electrode group. The electrode group was threaded into a 20-gauge hypodermic needle, which was used to insert the electrodes into the midmyocardium to a depth of 4 to 6 mm. The needle was then withdrawn, leaving the electrode group embedded in the myocardium. As many as 25 electrode groups were used in each experiment.
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In three experiments, epicardial conduction velocity in the center of the ischemic zone was measured using an epicardial plaque electrode with 90 closely spaced (500-to 900-,um interelectrode distance) unipolar electrode sites. The outside dimension of the plaque was 43 x43 mm. A row of bipolar pacing leads at the lateral edge of the plaque oriented perpendicular to the long axis of the epicardial fibers was used to pace the ventricles at 110 to 120 beats per minute. Activation times for all recording sites were used to generate activation sequence maps, which were then used to calculate conduction velocities along the long axis of the epicardial fibers.
Experimental Protocol
No intervention was performed for 40 minutes after electrode placement and cannulation of the LAD. We then performed several interventions in varying order, each separated by 50 minutes of recovery. of the zone was reached, flow into the LAD shunt and sidearm was abruptly terminated for 5 minutes or until ventricular fibrillation ensued. We refer to this process as "K'-modified ischemia." When ventricular fibrillation occurred, shunt flow was restored, and direct current defibrillation was performed.
In seven experiments, sequential episodes of K'-modified ischemia were performed. In an additional five experiments, the effects of verapamil were studied during K'-modified ischemia. In these experiments, a "control" episode of K+-modified ischemia was followed by a second episode of K+-modified ischemia that was identical to the control episode except that verapamil was infused along with the KCI solution into the LAD shunt for 5 minutes at a rate of 0.025 mg/min (calculated to deliver 0.5 gm/mL of verapamil). In an additional four experiments, a similar protocol was used to study the effects of glibenclamide during K'-modified ischemia.
The regional infusion of KCI produced no change in LAD flow as measured by the Doppler flow probe located in the shunt. Intramyocardial temperature within the distal LAD bed did not differ from intramyocardial temperature outside the zone perfused by the LAD shunt or from the core temperature. Arrest of flow through the LAD shunt produced a fall in intramyocardial temperature of less than 0.5°C. Regional KCI infusion produced no rise in the arterial K' or in the myocardial [K+] . outside the zone perfused by the shunt.
Data Collection and Analysis
The signals from all electrodes were individually amplified by high-impedance amplifiers. The An example of the marked activation delay that occurs during K'-modified ischemia is shown in Fig 3, which shows the surface ECG (channel 1), one bipolar electrogram in the nonischemic zone (channel 2), and three bipolar electrograms from the center of the ischemic zone (channels 3 through 5). Fig 3A shows 2.5 minutes after the onset of K'-modified ischemia. After 2.5 minutes of K'-modified ischemia (immediately preceding ventricular fibrillation), activation delay reached 234 to 288 milliseconds. In addition, 2:1 activation block is present, which was a frequent occurrence immediately preceding the onset of ventricular fibrillation.
Conduction Velocity
We measured epicardial longitudinal conduction velocity during both unmodified ischemia and K+-modified ischemia in three experiments using an epicardial plaque electrode. The results of one such experiment are shown in Fig 4. During unmodified ischemia, conduction velocity fell to 21 cm/s, after which conduction block occurred at 6 minutes into ischemia. During K'-modified ischemia in the same animal, longitudinal conduction velocity fell to 9 cm/s, after which ventricular fibrillation occurred. Similar results were observed in two additional experiments with K+-modified ischemia producing an epicardial longitudinal conduction velocity of less than 10 cm/s.
Effects of Verapamil
We measured the effects of verapamil on activation delay during K'-modified ischemia in five experiments.
The results of one such experiment are shown in Fig 5. During the control episode of K'-modified ischemia, activation delay reached 205 milliseconds, culminating in ventricular fibrillation. The same protocol was then repeated in the presence of verapamil. Verapamil had no effect on the activation delay associated with the KCl infusion. During the initial minutes of K'-modified ischemia, verapamil slowed the development of further activation delay. After several minutes of K'-modified ischemia, activation became progressively more delayed, but the marked activation delay that occurred during the control episode did not occur in the presence of verapamil. Instead, local activation block occurred after activation delay reached a maximum of 85 milliseconds. Three additional experiments produced similar results, ie, inhibition of marked activation delay by producing local activation block following activation delay of approximately 60 to 80 milliseconds. In this ,mol/L). This concentration is similar to that used by others in isolated, perfused rat16 and rabbit17 hearts and produces blood levels 20 to 60 times greater than that observed during the intravenous administration of 1.5 mg/kg in the in situ dog heart.8 Moreover, we observed in a pilot series of experiments that the intracoronary administration of 10 to 30 ,umol/L glibenclamide less- ened the rise in extracellular K' induced by a 10-minute period of no-flow ischemia. As shown in the figure, glibenclamide had no effect on activation delay during K+-modified ischemia and did not inhibit the development of marked activation delay in this setting. Glibenclamide did not prevent the occurrence of ventricular fibrillation during K+-modified ischemia in any of the four experiments.
High [K']e Plus Epinephrine
To determine the magnitude of the activation delay associated with responses known to be mediated by the slow inward current,4,5,19 we performed two experiments in which we raised the regional [K+]e to 15 mmol/L to fully inactivate the rapid inward current, and then we simultaneously administered epinephrine (10`mol/L). during K+-modified ischemia. In a second similar experiment, regional infusion of KCl resulted in local activation block following a maximum activation delay of 75 milliseconds, whereas coadministration of epinephrine resulted in return of local activation with an activation delay of 180 milliseconds. In both of these experiments, frequent episodes of nonsustained ventricular tachycardia occurred during the local epinephrine administration, but ventricular fibrillation did not occur.
Discussion
The conduction slowing that occurs during the first 10 minutes of acute ischemia is believed to be due to depression of the rapid inward (Na+) current.1'19 Responses mediated by the slow inward (Ca'+) current have been produced experimentally by inactivating the rapid inward current with the high [K+]e or tetrodotoxin419-2' (usually in combination with exogenous catecholamines as well) but have not previously been identified during acute ischemia. In this study, we have shown that altering the ionic conditions by raising [K'], before the onset of ischemia (K+-modified ischemia) results in marked conduction slowing that we believe is mediated by the slow inward current. The experimental evidence supporting the assertion that K'-modified ischemia results in conduction mediated by the slow inward current is summarized in Fig 8 and includes Fig 8, the maximum activation delay during regional KCl infusion (in the absence of epinephrine) was very similar to the maximum activation delay during K'-modified ischemia in the presence of verapamil. In both circumstances, this maximum activation delay represents the maximum degree of conduction slowing of Na+ channel-mediated responses before failure of impulse propagation. Although high [K']e alone produced a maximum activation delay of 76 milliseconds before the onset of local activation block, local activation could be restored by regional infusion of epinephrine. As shown in Fig 8, the mean activation delay of these slow channel-mediated responses in these two experiments was similar to the activation delay observed during K'-modified ischemia.
The assertion that the marked activation delay during K+-modified ischemia represents slow channel-mediated conduction is further supported by studies that we have performed in the arterially perfused rabbit papillary muscle in which K+-modified ischemia was produced in a manner similar to that reported in this study,29 resulting in slow responses and a conduction velocity of 5 cm/s. The very slow conduction in the rabbit papillary muscle was likewise inhibited by verapamil.
As referred to above, the conduction slowing that occurs before the onset of local activation block in the center of the ischemic zone during unmodified ischemia has been attributed to depression of the rapid inward (Na+) current' '9 rather than to activation of the slow inward current. In the center of the ischemic zone, the absence of responses mediated by the slow inward current during unmodified ischemia may relate to the associated fall in pH. It 
